Baillie Gifford & Co
SCR

Baillie Gifford & Co’s SIMCERE PHARMACEUTICAL GROUP, ADS SCR Stock Holding History

Baillie Gifford & Co’s Portfolio SCR Stock Details SCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-24,400
Closed -$236K – 217
2013
Q4 		$236K Hold
24,400
– – ﹤0.01% 198
2013
Q3 		$231K Hold
24,400
– – ﹤0.01% 191
2013
Q2 		$231K Buy
+24,400
New +$226K ﹤0.01% 166

Baillie Gifford & Co's SCR Position: Q1 2014 in Review

Baillie Gifford & Co sold out of SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) in Q1 2014, closing a stake of 24,400 shares — an estimated $236K sold.

Baillie Gifford & Co first reported a position in SCR in Q2 2013 and held it in 3 quarters. The position peaked at $236K in Q4 2013. 0 funds tracked by Wall St. Rank hold SCR as of Q1 2014.

  • Baillie Gifford & Co reported no remaining SIMCERE PHARMACEUTICAL GROUP, ADS position as of Q1 2014 after selling out during the quarter.
  • Baillie Gifford & Co sold 24,400 SIMCERE PHARMACEUTICAL GROUP, ADS shares in Q1 2014, an estimated $236K.
  • Baillie Gifford & Co first reported a position in SIMCERE PHARMACEUTICAL GROUP, ADS in Q2 2013 and held it in 3 quarters.
  • Baillie Gifford & Co's SIMCERE PHARMACEUTICAL GROUP, ADS position peaked at $236K in Q4 2013.
  • 0 funds tracked by Wall St. Rank held SIMCERE PHARMACEUTICAL GROUP, ADS as of Q1 2014.

Based on Baillie Gifford & Co's 13F filing for Q1 2014, filed 1 May 2014.